Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07TGY
|
|||
Former ID |
DIB015590
|
|||
Drug Name |
Indeloxazine
|
|||
Synonyms |
Elen; Noin; Indeloxazine hydrochloride; YM-08054
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Dementia [ICD-11: 6D80-6D86] | Approved | [1] | |
Company |
Yamanouchi Pharmaceutical Co Ltd
|
|||
Structure |
Download2D MOL |
|||
Formula |
C14H17NO2
|
|||
Canonical SMILES |
C1COC(CN1)COC2=CC=CC3=C2CC=C3
|
|||
InChI |
1S/C14H17NO2/c1-3-11-4-2-6-14(13(11)5-1)17-10-12-9-15-7-8-16-12/h1-4,6,12,15H,5,7-10H2
|
|||
InChIKey |
MADRVGBADLFHMO-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 60929-23-9
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:5894
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Monoamine oxidase type B (MAO-B) | Target Info | Modulator | [1] |
BioCyc | Superpathway of tryptophan utilization | |||
Tryptophan degradation via tryptamine | ||||
Dopamine degradation | ||||
Putrescine degradation III | ||||
Noradrenaline and adrenaline degradation | ||||
KEGG Pathway | Glycine, serine and threonine metabolism | |||
Arginine and proline metabolism | ||||
Histidine metabolism | ||||
Tyrosine metabolism | ||||
Phenylalanine metabolism | ||||
Tryptophan metabolism | ||||
Drug metabolism - cytochrome P450 | ||||
Metabolic pathways | ||||
Serotonergic synapse | ||||
Dopaminergic synapse | ||||
Cocaine addiction | ||||
Amphetamine addiction | ||||
Alcoholism | ||||
Panther Pathway | Adrenaline and noradrenaline biosynthesis | |||
5-Hydroxytryptamine degredation | ||||
Dopamine receptor mediated signaling pathway | ||||
Pathway Interaction Database | Alpha-synuclein signaling | |||
WikiPathways | Tryptophan metabolism | |||
Dopamine metabolism | ||||
Phase 1 - Functionalization of compounds |
References | Top | |||
---|---|---|---|---|
REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.